We are live on ! Find out more
IART icon

Integra LifeSciences
IART

131 hedge funds and large institutions have $893M invested in Integra LifeSciences in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 46 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 10

13% more capital invested

Capital invested by funds: $791M → $893M (+$101M)

2% more funds holding

Funds holding: 129 → 131 (+2)

9% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 46

90% less call options, than puts

Call options by funds: $8K | Put options by funds: $81K

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
131
Holders Change
+2
Holders Change %
+1.55%
% of All Funds
4.25%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
16
Increased
50
Reduced
46
Closed
10
Calls
$8K
Puts
$81K
Net Calls
-$73K
Net Calls Change
-$351K

Top Buyers

1
Invesco
Invesco
Georgia
+$6.77M
2
ClearBridge Investments
ClearBridge Investments
New York
+$5.56M
3
B
Barings
North Carolina
+$5.03M
4
BFA
BlackRock Fund Advisors
California
+$4.49M
5
Wells Fargo
Wells Fargo
California
+$2.92M

Top Sellers

1
BC
Broadfin Capital
New York
-$11.1M
2
Deutsche Bank
Deutsche Bank
Germany
-$10.2M
3
DM
Deerfield Management
New York
-$9.45M
4
CI
Cambiar Investors
Colorado
-$3.3M
5
EVM
Eaton Vance Management
Massachusetts
-$2.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
WC
126
Whitnell & Co
Illinois
$5K – – –
Envestnet Asset Management
127
Envestnet Asset Management
Illinois
$1K -$144 -9 -18%
PTC
128
Private Trust Company
Ohio
$1K – – –
S
129
SignatureFD
Georgia
$1K – – –
Manulife (Manufacturers Life Insurance)
130
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$636 -$38.8K -2,420 -6%
DM
131
Deerfield Management
New York
– -$9.45M -631,297 Closed
EVM
132
Eaton Vance Management
Massachusetts
– -$2.94M -196,694 Closed
CIC
133
Cornercap Investment Counsel
Georgia
– -$1.71M -114,096 Closed
Susquehanna International Group
134
Susquehanna International Group
Pennsylvania
– -$423K -28,262 Closed
GC
135
Guggenheim Capital
Illinois
– -$231K -15,430 Closed
MCM
136
Mazama Capital Management
Oregon
– -$20K -1,341 Closed
OMCS
137
Old Mutual Customised Solutions
South Africa
– -$15K -979 Closed
TFA
138
Transamerica Financial Advisors
Florida
– -$10K -612 Closed
Creative Planning
139
Creative Planning
Kansas
– -$7K -489 Closed
2 3 4 5
6

IART Hedge Fund Activity: Q3 2013 in Review

131 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2013, worth a combined $893M — up 13% from $791M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new IART positions and 10 closed out — a net gain of 6 holders — while 50 added to existing stakes and 46 trimmed.

The largest buyer was Invesco, adding an estimated $6.77M. The largest seller was Broadfin Capital, cutting an estimated $11.1M.

  • 131 institutional investors held Integra LifeSciences (IART) as of Q3 2013, up from 129 in Q2 2013.
  • Funds reported $893M of Integra LifeSciences stock for Q3 2013, up 13% quarter-over-quarter.
  • 16 funds opened new Integra LifeSciences positions in Q3 2013 and 10 closed out, a net change of +6 holders.
  • The largest Integra LifeSciences buyer in Q3 2013 was Invesco, an estimated $6.77M added.
  • The largest Integra LifeSciences seller in Q3 2013 was Broadfin Capital, an estimated $11.1M sold.

Based on aggregated 13F filings for Q3 2013.